216 related articles for article (PubMed ID: 19333934)
1. Anti-U3 RNP autoantibodies in systemic sclerosis.
Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA
Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934
[TBL] [Abstract][Full Text] [Related]
2. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
Steen V; Domsic RT; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2012 Sep; 64(9):2986-94. PubMed ID: 22576620
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
[TBL] [Abstract][Full Text] [Related]
4. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
Fertig N; Domsic RT; Rodriguez-Reyna T; Kuwana M; Lucas M; Medsger TA; Feghali-Bostwick CA
Arthritis Rheum; 2009 Jul; 61(7):958-65. PubMed ID: 19565553
[TBL] [Abstract][Full Text] [Related]
5. Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.
Nandiwada SL; Peterson LK; Mayes MD; Jaskowski TD; Malmberg E; Assassi S; Satoh M; Tebo AE
J Rheumatol; 2016 Oct; 43(10):1816-1824. PubMed ID: 27481902
[TBL] [Abstract][Full Text] [Related]
6. Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex.
Yang JM; Hildebrandt B; Luderschmidt C; Pollard KM
Arthritis Rheum; 2003 Jan; 48(1):210-7. PubMed ID: 12528121
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors.
McNearney TA; Reveille JD; Fischbach M; Friedman AW; Lisse JR; Goel N; Tan FK; Zhou X; Ahn C; Feghali-Bostwick CA; Fritzler M; Arnett FC; Mayes MD
Arthritis Rheum; 2007 Mar; 57(2):318-26. PubMed ID: 17330281
[TBL] [Abstract][Full Text] [Related]
9. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.
Tall F; Dechomet M; Riviere S; Cottin V; Ballot E; Tiev KP; Montin R; Morin C; Chantran Y; Grange C; Jullien D; Ninet J; Chretien P; Cabane J; Fabien N; Johanet C
Scand J Immunol; 2017 Jan; 85(1):73-79. PubMed ID: 27864990
[TBL] [Abstract][Full Text] [Related]
12. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
[TBL] [Abstract][Full Text] [Related]
13. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
14. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
15. Anti-U3 ribonucleoprotein antibody-positive inflammatory myopathy: a case report.
Murata KY; Nakatani K; Yananeki M; Nakanishi I; Ito H
J Med Case Rep; 2016 Jun; 10():169. PubMed ID: 27283724
[TBL] [Abstract][Full Text] [Related]
16. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
17. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
18. Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.
Satoh M; Krzyszczak ME; Li Y; Ceribelli A; Ross SJ; Chan EK; Segal MS; Bubb MR; Sobel ES; Reeves WH
Arthritis Res Ther; 2011 May; 13(3):R73. PubMed ID: 21569292
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
[TBL] [Abstract][Full Text] [Related]
20. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
Sacks DG; Okano Y; Steen VD; Curtiss E; Shapiro LS; Medsger TA
J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
